BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8099860)

  • 1. Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Machold KP; Kiener HP; Graninger W; Graninger WB
    Clin Immunol Immunopathol; 1993 Jul; 68(1):74-8. PubMed ID: 8099860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of serum levels of soluble intercellular adhesion molecule-1 with disease activity in systemic lupus erythematosus.
    Sari RA; Taysi S; Erdem F; Yilmaz O; Keleş S; Kiziltunç A; Odabaş AR; Cetinkaya R
    Rheumatol Int; 2002 Jan; 21(4):149-52. PubMed ID: 11843170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating intercellular adhesion molecule 1 as a new activity marker in patients with systemic lupus erythematosus.
    Kling E; Bieg S; Boehme M; Scherbaum WA
    Clin Investig; 1993 Apr; 71(4):299-304. PubMed ID: 8097124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study.
    Spronk PE; Bootsma H; Huitema MG; Limburg PC; Kallenberg CG
    Clin Exp Immunol; 1994 Sep; 97(3):439-44. PubMed ID: 7521807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Lack of correlation with levels of circulating vascular cell adhesion molecule 1.
    Mason JC; Kapahi P; Haskard DO
    Arthritis Rheum; 1993 Apr; 36(4):519-27. PubMed ID: 7681283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble intercellular adhesion molecule-1 in arthritis.
    Koch AE; Shah MR; Harlow LA; Lovis RM; Pope RM
    Clin Immunol Immunopathol; 1994 May; 71(2):208-15. PubMed ID: 7910125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with systemic lupus erythematosus.
    Tulek N; Aydintug O; Ozoran K; Tutkak H; Duzgun N; Duman M; Tokgoz G
    Clin Rheumatol; 1996 Jan; 15(1):47-50. PubMed ID: 8929775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis.
    Blann AD; Herrick A; Jayson MI
    Br J Rheumatol; 1995 Sep; 34(9):814-9. PubMed ID: 7582719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
    Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
    Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on soluble intercellular adhesion molecule-1 and selenium in patients with rheumatoid arthritis complicated by vasculitis.
    Witkowska AM; Kuryliszyn-Moskal A; Borawska MH; Hukałowicz K; Markiewicz R
    Clin Rheumatol; 2003 Dec; 22(6):414-9. PubMed ID: 14677018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
    Wais T; Fierz W; Stoll T; Villiger PM
    J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble intercellular adhesion molecule 1 in spondylarthropathies.
    Wendling D; Racadot E; Augé B; Toussirot E
    Clin Rheumatol; 1998; 17(3):202-4. PubMed ID: 9694052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus.
    Srivastava MD; Rossi TM; Lebenthal E
    Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):21-6. PubMed ID: 7735726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis.
    Kaplanski G; Cacoub P; Farnarier C; Marin V; Grégoire R; Gatel A; Durand JM; Harlé JR; Bongrand P; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):55-64. PubMed ID: 10643700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of antioxidant proteins and soluble intercellular adhesion molecule-1 in serum of patients with rheumatoid arthritis.
    Cogalgil S; Taysi S
    Ann Clin Lab Sci; 2002; 32(3):264-70. PubMed ID: 12175089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated soluble intercellular adhesion molecule-1 levels in patients with systemic lupus erythematosus: relation to insulin resistance.
    Tso TK; Huang WN
    J Rheumatol; 2007 Apr; 34(4):726-30. PubMed ID: 17309130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum soluble adhesion molecules--sICAM-1, sVCAM-1, sE-selectin--in patients with systemic rheumatoid arthritis].
    Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
    Pol Merkur Lekarski; 2004 Oct; 17(100):353-6. PubMed ID: 15690700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
    López-Lerma I; Estrach MT
    J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
    Ann Rheum Dis; 2002 Sep; 61(9):804-9. PubMed ID: 12176805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of soluble ICAM-1 by mononuclear cells from patients with rheumatoid arthritis patients.
    Shingu M; Hashimoto M; Nobunaga M; Isayama T; Yasutake C; Naono T
    Inflammation; 1994 Feb; 18(1):23-34. PubMed ID: 7911453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.